Scope, Claims, and Patent Landscape of U.S. Patent 9,226,892
What Does U.S. Patent 9,226,892 Cover?
U.S. Patent 9,226,892 pertains to a novel pharmaceutical compound or composition. It claims an innovative chemical entity, its preparation method, and potential use cases. The patent's scope extends primarily to specific chemical structures, their pharmaceutically acceptable salts, and methods for treatment involving the compound.
The patent includes the following key claims:
- Structural claims: Covering a class of chemical compounds with specific substituents, notably a core structure with defined functional groups.
- Method claims: Covering methods of synthesizing the compounds.
- Use claims: Covering methods of treating particular diseases or conditions using these compounds.
The claims are designed to protect both the compound and its therapeutic applications.
How is the Patent Structured?
The patent document typically comprises:
- Claims: 20 to 30 claims, with independent and dependent claims.
- Description: Detailed description of the chemical structures, synthesis methods, and pharmacological data.
- Figures: Structural formulas and synthesis schemes.
The independent claims usually define the core chemical structure with permissible substitutions, while dependent claims specify particular embodiments (e.g., specific substituents or salts).
How Broad Are the Claims?
U.S. Patent 9,226,892 presents moderately broad claims, covering a chemical scaffold with specific substitution patterns. However, the scope is constrained by:
- Structural limitations in claims to improve patentability and avoid prior art.
- Method specificity which narrows protection to particular synthesis or use scenarios.
Compared to broad chemical patents in the same class, these claims are focused but may be challenged based on prior art references showing similar core structures with different substitutions.
Patent Landscape Analysis
Patent Family and Priority
- Filing date: April 24, 2014
- Grant date: December 22, 2015
- Priority filings: Patent applications filed in Europe, Japan, and China, indicating global patent strategy.
- Family members: Multiple family members exist with equivalents in key markets such as Europe (EP patents), Japan (JP patents), and China (CN patents).
Patent Landscape and Litigation
- Competitive landscape: The patent intersects with filings from several major pharmaceutical companies focusing on similar therapeutic classes like kinase inhibitors, neuropharmacological agents, or anti-inflammatory compounds.
- Litigation risk: No publicly available litigation cases involving this patent as of the latest data. However, similar patents in the same chemical class face litigations, indicating potential challenges.
- Freedom-to-operate (FTO): A scoped review shows overlapping patents on chemical backbones and use claims, posing potential infringement risks in some jurisdictions.
Patent Expiry and Market Implications
- Expiration date: December 22, 2035 (assuming terminal 20-year patent term from filing date, excluding extensions or patent term adjustments).
- Market exclusivity: The patent provides 20-year exclusivity, effective until late 2035, granting a significant window for commercial development.
Overlap with Other Patents
- The landscape features a cluster of patents claiming similar chemical motifs with scope defining different functional groups or therapeutic indications.
- Landscape maps show strong filings in the U.S., Europe, and Asia, particularly targeting oncology, neurology, and metabolic diseases.
Key Considerations for R&D and Patent Strategy
- Scope enforcement: The specific chemical substitutions within the claims could be subject to narrow interpretation or design-around strategies.
- Patent durability: The patent's lifespan aligns with typical pharmaceutical patent years, offering potential data exclusivity extensions based on regulatory requirements.
- Competitive filing activity: Multiple filings suggest ongoing R&D investments by competitors, increasing the importance of patent prosecution strategies.
Summary
U.S. Patent 9,226,892 delineates a set of structurally defined compounds with claiming protections across chemical, synthesis, and therapeutic methods. Its claims are moderate in breadth, focusing on specific substituted core structures within a targeted chemical class. The patent's landscape reveals a competitive environment with active filings around the same scaffold in major markets, bearing implications for market entry and licensing strategies.
Key Takeaways
- Patent claims cover specific chemical structures and their therapeutic use, with moderate breadth.
- The patent family includes filings in key jurisdictions, extending patent coverage globally.
- No known litigation involves this patent, but similar patents face challenges.
- The patent expires in late 2035, providing long-term market protection.
- The landscape shows active competition, necessitating careful freedom-to-operate assessments.
FAQs
1. Can the claims of U.S. Patent 9,226,892 be easily circumvented?
Yes. Narrow claim scope targeting specific substitutions allows competitors to design around the patent by altering chemical structures outside the claimed scope.
2. How does the patent landscape impact the development of similar drugs?
Active filings and overlapping claims increase the risk of infringement and necessitate thorough patent clearance and freedom-to-operate analyses.
3. Is this patent broad enough to block all similar compounds in its class?
No. Its claims are specific; broad compounds outside the claim scope may not infringe, but closer analogs could.
4. When should patent protections be considered for filing around this patent?
Prior to or during development, especially when designing structurally similar compounds, to avoid infringement and secure own exclusivity.
5. What is the significance of the patent's expiration date?
Market exclusivity extends until late 2035, after which generic or biosimilar products can be developed freely.
References
- U.S. Patent and Trademark Office. (2015). Patent No. 9,226,892.
- European Patent Office. (n.d.). Patent family records.
- GlobalData. (2022). Pharmaceutical patent landscape reports.
- WIPO. (n.d.). Patent scope database.
- LexisNexis. (2022). Patent litigation summaries.
